Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2626)	10/12/2009 11:51:07 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

DEPO tanked today. It opened with a huge DG that more than completely closed its Oct 5 UG.<g> The stock is still down 38.84% with volume of 6,800,000 already above the 5,600,300 traded on Oct 5 and about 1.5x its ADV. bigcharts.marketwatch.com It reported results from 2 PIIIs evaluating non-hormonal therapy for menopausal hot flashes. But it said that Serada missed several of its goals.<g> The PIIIs tested two doses of Serada, and while the drug was generally successful after four weeks of testing, it missed most of its key goals after 12 weeks. The higher dose met its four main goals after four weeks, but missed three of the four goals after 12 weeks.The lower dose met three of the four primary goals after four weeks, and met only one of the goals after 12 weeks. As previously mentioned, it was better to wait for DEPO fo close the Oct 5 UG. Now will watch for further developments.<g> bigcharts.marketwatch.com Bernard